In His First Public Performance, TrovaGene's New CEO Gets High Marks All Around

Liquid Biopsy play TrovaGene Inc. (Nasdaq: TROV) issued its first-quarter financial results Tuesday, reporting a net loss that was slightly wider than expected.

But the real focus was on new William Welch - hired last month following a development that prompted TrovaGene to fire its two top executives.

  1. William Burton | May 13, 2016

    Sounds like it will be awhile on this one. But it's true that no matter how good a product is ,that without a marketing platform,it's not going anywhere. Let's hope trov's worse is behind them Talk to you at the next REAL quarter and then look back on this nonsense! And say SELLS MAKES THE WORLD GO'ROUND !

    • (Admin) Bill Patalon | May 16, 2016

      Dear William:
      Exceptionally well-stated.
      Always glad to hear from you.
      By the way … you have a GREAT first name.
      Respectfully;
      William Patalon III
      Executive Editor/Editorial Director
      Money Map Press
      Editor: Private Briefing

    • (Admin) Bill Patalon | May 16, 2016

      P.S., William … keep an eye out for a new update … in the works, now.
      WP III

Leave a Reply

Your email address will not be published. Required fields are marked *


Some HTML is OK